SciELO - Scientific Electronic Library Online

vol.49 issue2Draft genome sequence of Paraburkholderia tropica Ppe8 strain, a sugarcane endophytic diazotrophic bacterium author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand




Related links


Brazilian Journal of Microbiology

Print version ISSN 1517-8382On-line version ISSN 1678-4405

Braz. J. Microbiol. vol.49 no.2 São Paulo Apr./June 2018 

Genome Announcements

Genome sequence of Streptomyces gilvigriseus MUSC 26T isolated from mangrove forest

Hooi-Leng Sera  b  c 

Wen-Si Tand 

Nurul-Syakima Ab Mutalibe 

Wai-Fong Yind 

Kok-Gan Chand  f 

Bey-Hing Goha  c  g  h 

Learn-Han Leea  b  c  g  h  * 

aMonash University Malaysia, School of Pharmacy, Novel Bacteria and Drug Discovery Research Group (NBDD), Selangor Darul Ehsan, Malaysia

bMonash University Malaysia, Jeffrey Cheah School of Medicine and Health Sciences, Biomedical Research Laboratory, Selangor Darul Ehsan, Malaysia

cMonash University Malaysia, School of Pharmacy, Biofunctional Molecule Exploratory Research Group (BMEX), Bandar Sunway, Malaysia

dUniversity of Malaya, Faculty of Science, Institute of Biological Sciences, Division of Genetics and Molecular Biology, Malaysia

eUniversiti Kebangsaan Malaysia, UKM Medical Centre, UKM Medical Molecular Biology Institute (UMBI), Kuala Lumpur, Malaysia

fVice Chancellor Office, Jiangsu University, Zhenjiang 212013, PR China

gUniversity of Phayao, School of Pharmaceutical Sciences, Center of Health Outcomes Research and Therapeutic Safety (Cohorts), Phayao, Thailand

hMonash University Malaysia, Global Asia in the 21st Century (GA21) Platform, Health and Well-being Cluster, Implementation and Clinical Outcomes (PICO), Asian Centre for Evidence Synthesis in Population, Bandar Sunway, Malaysia


Streptomycetes remain as one of the important sources for bioactive products. Isolated from the mangrove forest, Streptomyces gilvigriseus MUSC 26T was previously characterised as a novel streptomycete. The high quality draft genome of MUSC 26T contained 5,213,277 bp with G + C content of 73.0%. Through genome mining, several gene clusters associated with secondary metabolites production were revealed in the genome of MUSC 26T. These findings call for further investigations into the potential exploitation of the strain for production of pharmaceutically important compounds.

Keywords: Genome sequence; Streptomyces gilvigriseus; Mangrove; AntiSMASH; Neuroprotective

The members of Streptomyces are of great importance for bioactive products; these organisms are capable of producing a range of structurally diverse compounds with various bioactivities including antibiotics, anti-rejection (immunosuppressant), antioxidant and anticancer.1-5 As a novel streptomycete isolated from mangrove forest, Streptomyces gilvigriseus MUSC 26T has been deposited in two culture collection centres (=MCCC 1K00252T = DSM 42140T). The methanolic extract of MUSC 26T was prepared as previously described and it has demonstrated significant neuroprotective activity against free radical-induced damage in SHSY-5Y neuronal cells (data not shown).4,6,7 Thus, the strain MUSC 26T was selected for genome sequencing as an attempt to identify biosynthetic gene clusters associated with secondary metabolites production.

Genomic DNA extraction of MUSC 26T was carried out with MasterpureTM DNA purification kit (Epicentre, Illumina Inc., Madison, WI, USA) before RNase (Qiagen, USA) treatment.8,9 DNA quality was accessed using NanoDrop spectrophotometer (Thermo Scientific, Waltham, MA, USA) and a Qubit version 2.0 fluorometer (Life Technologies, Carlsbad, CA, USA). Construction of DNA library was performed using Nextera™ DNA Sample Preparation kit (Nextera, USA) and the library quality was validated by Bioanalyser 2100 high sensitivity DNA kit (Agilent Technologies, Palo Alto, CA) prior to performing paired-end sequencing on MiSeq platform with MiSeq Reagent Kit 2 (2 × 250 bp; Illumina Inc., Madison, WI, USA). The paired-end reads were trimmed and de novo assembled with CLC Genomics Workbench version 7 (CLC bio, Denmark). The analysis generated 206 contigs with N50 size of 45,324 bp (Table 1). The assembled genome size of MUSC 26T contained 5,213,277 bp, with an average coverage of 40.0-fold and G + C content of 73.0%. The whole genome project of MUSC 26T was deposited at DDBJ/EMBL/GenBank under accession number MLCF00000000 and the version described in this paper is the first version (MLCF01000000).

Table 1 General features of Streptomyces gilvigriseus MUSC 26T genome. 

Streptomyces gilvigriseus MUSC 26T
Genome size (bp) 5,213,277
Contigs 206
Contigs N50 (bp) 45,324
G + C content (%) 73.0
Protein coding genes 4337
tRNA 53
rRNA 1 (5S), 3 (16S), 1 (23S)

Gene prediction was performed using Prodigal version 2.6, whereas rRNA and tRNA were predicted using RNAmmer and tRNAscan SE version 1.21.10-12 The assembly was uploaded for annotation to Rapid Annotation using Subsystem Technology (RAST).13 A total of 4337 protein-encoding genes was predicted and assigned to 363 subsystems, along with 53 tRNA and 5 rRNA genes. Among the subsystems, most of the genes were involved in carbohydrates metabolism (7.39%), followed by amino acids and derivatives metabolism (5.90%) and protein metabolism subsystems (5.81%).

The genomic potential of MUSC 26T was further explored with antibiotics & Secondary Metabolite analysis shell (antiSMASH), PRediction Informatics for Secondary Metabolomes (PRISM) and BAGEL3.14-17 The antiSMASH server detected two gene clusters associated with siderophores production; one of which showed 40% similarities to desferrioxamine B biosynthetic gene cluster. The presence of these biosynthetic gene clusters suggest possible production of compounds responsible for the neuroprotective activity. Apart from siderophores, PRISM and BAGEL3 detected two gene clusters associated with class I lantipeptide and one gene cluster associated with lasso peptide and bacteriocin, respectively. Overall, these findings highlighted the genomic potential of MUSC 26T and prompted further comprehensive studies to allow utilisation of the strain for production of pharmaceutically important compounds.


This work was supported by PVC Award Grant (Project Q7 No. PVC-ECR-2016), External Industry Grant (Biotek Abadi Vote No. GBA-808813), MOSTI eScience funds (Project No. 06-02-10-SF0300) awarded to L.-H.L. and MOSTI eScience funds (Project No. 02-02-10-SF0215) awarded to B.-H.G., and a University of Malaya for High Impact Research Grant (UM-MOHE HIR Nature Microbiome Grant No. H-50001-A000027 and No. A000001-50001) and PPP Grant (PG090-2015B) awarded to K.-G.C.


1 Berdy J. Bioactive microbial metabolites. J Antibiotics. 2005;58:1-26. [ Links ]

2 Solecka J, Zajko J, Postek M, Rajnisz A. Biologically active secondary metabolites from Actinomycetes. Open Life Sci. 2012;7(3):373-390. [ Links ]

3 Tan LTH, Ser HL, Yin WF, Chan KG, Lee LH, Goh BH. Investigation of antioxidative and anticancer potentials of Streptomyces sp. MUM256 isolated from Malaysia mangrove soil. Front Microbiol. 2015;6:1316. [ Links ]

4 Ser HL, Tan LTH, Palanisamy UD, et al. Streptomyces antioxidans sp. nov., a novel mangrove soil actinobacterium with antioxidative and neuroprotective potentials. Front Microbiol. 2016;7:899. [ Links ]

5 Ser HL, Palanisamy UD, Yin WF, Chan KG, Goh BH, Lee LH. Streptomyces malaysiense sp. nov.: a novel Malaysian mangrove soil actinobacterium with antioxidative activity and cytotoxic potential against human cancer cell lines. Sci Rep. 2016;6:24247. [ Links ]

6 Lee LH, Zainal N, Azman AS, et al. Diversity and antimicrobial activities of actinobacteria isolated from tropical mangrove sediments in Malaysia. Sci World J. 2014;698178:1-14. [ Links ]

7 Ser HL, Zainal N, Palanisamy UD, et al. Streptomyces gilvigriseus sp. nov., a novel actinobacterium isolated from mangrove forest soil. Antonie van Leeuwenhoek. 2015;107:1369-1378. [ Links ]

8 Ser HL, Tan WS, Ab Mutalib NS, et al. Genome sequence of Streptomyces pluripotens MUSC 135T exhibiting antibacterial and antioxidant activity. Mar Gen. 2015;24:281-283. [ Links ]

9 Ser HL, Tan WS, Ab Mutalib NS, et al. Draft genome sequence of mangrove-derived Streptomyces sp. MUSC 125 with antioxidant potential. Front Microbiol. 2016;7:1470. [ Links ]

10 Lowe TM, Eddy SR. tRNAscan-SE: a program for improved detection of transfer RNA genes in genomic sequence. Nucleic Acids Res. 1997;25:955-964. [ Links ]

11 Lagesen K, Hallin P, Rodland EA, et al. consistent and rapid annotation of ribosomal RNA genes. Nucleic Acids Res. 2007;35:3100-3108. [ Links ]

12 Hyatt D, Chen GL, Locascio PF, Land ML, Larimer FW, Hauser LJ. Prodigal: prokaryotic gene recognition and translation initiation site identification. BMC Bioinf. 2010;11:119. [ Links ]

13 Aziz RK, Bartels D, Best AA, et al. The RAST Server: rapid annotations using subsystems technology. BMC Gen. 2008;9:75. [ Links ]

14 Weber T, Blin K, Duddela S, et al. antiSMASH 3.0-a comprehensive resource for the genome mining of biosynthetic gene clusters. Nucleic Acids Res. 2015;43:W237-W243. [ Links ]

15 Skinnider MA, Dejong CA, Rees PN, et al. Genomes to natural products prediction informatics for secondary metabolomes (PRISM). Nucleic Acids Res. 2015;43:9645-9662. [ Links ]

16 Skinnider MA, Johnston CW, Edgar RE, et al. Genomic charting of ribosomally synthesized natural product chemical space facilitates targeted mining. PNAS. 2016;113:E6343-E6351. [ Links ]

17 Van Heel AJ, de Jong A, Montalban-Lopez M, Kok J, Kuipers OP. BAGEL3: automated identification of genes encoding bacteriocins and (non-) bactericidal posttranslationally modified peptides. Nucleic Acids Res. 2013;41:W448-W453. [ Links ]

Received: February 10, 2017; Accepted: April 3, 2017

*Corresponding authors at: School of Pharmacy, Monash University Malaysia, 47500 Bandar Sunway, Selangor Darul Ehsan, Malaysia. E-mails:, (L. Lee).

Conflicts of interest

The authors declare no conflicts of interest.

Creative Commons License This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivative License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium provided the original work is properly cited and the work is not changed in any way.